MSFT   213.03 (+1.11%)
GOOGL   1,520.29 (+1.38%)
NVDA   402.00 (+2.14%)
CGC   16.60 (-2.01%)
BABA   238.94 (-0.44%)
MU   50.12 (-1.57%)
GE   6.80 (-3.00%)
TSLA   1,403.27 (+2.31%)
AMD   53.56 (+0.30%)
T   30.35 (-0.46%)
ACB   12.22 (+0.33%)
DIS   113.42 (-0.87%)
BAC   23.06 (-2.54%)
NFLX   497.00 (+0.65%)
BA   181.07 (-3.64%)
MSFT   213.03 (+1.11%)
GOOGL   1,520.29 (+1.38%)
NVDA   402.00 (+2.14%)
CGC   16.60 (-2.01%)
BABA   238.94 (-0.44%)
MU   50.12 (-1.57%)
GE   6.80 (-3.00%)
TSLA   1,403.27 (+2.31%)
AMD   53.56 (+0.30%)
T   30.35 (-0.46%)
ACB   12.22 (+0.33%)
DIS   113.42 (-0.87%)
BAC   23.06 (-2.54%)
NFLX   497.00 (+0.65%)
BA   181.07 (-3.64%)
MSFT   213.03 (+1.11%)
GOOGL   1,520.29 (+1.38%)
NVDA   402.00 (+2.14%)
CGC   16.60 (-2.01%)
BABA   238.94 (-0.44%)
MU   50.12 (-1.57%)
GE   6.80 (-3.00%)
TSLA   1,403.27 (+2.31%)
AMD   53.56 (+0.30%)
T   30.35 (-0.46%)
ACB   12.22 (+0.33%)
DIS   113.42 (-0.87%)
BAC   23.06 (-2.54%)
NFLX   497.00 (+0.65%)
BA   181.07 (-3.64%)
MSFT   213.03 (+1.11%)
GOOGL   1,520.29 (+1.38%)
NVDA   402.00 (+2.14%)
CGC   16.60 (-2.01%)
BABA   238.94 (-0.44%)
MU   50.12 (-1.57%)
GE   6.80 (-3.00%)
TSLA   1,403.27 (+2.31%)
AMD   53.56 (+0.30%)
T   30.35 (-0.46%)
ACB   12.22 (+0.33%)
DIS   113.42 (-0.87%)
BAC   23.06 (-2.54%)
NFLX   497.00 (+0.65%)
BA   181.07 (-3.64%)
Log in

TSE:GUDKnight Therapeutics News Headlines

C$7.06
+0.01 (+0.14 %)
(As of 07/7/2020 12:04 PM ET)
Add
Compare
Today's Range
C$6.93
Now: C$7.06
C$7.13
50-Day Range
C$6.82
MA: C$7.25
C$7.64
52-Week Range
C$4.73
Now: C$7.06
C$8.88
Volume158,382 shs
Average Volume360,941 shs
Market CapitalizationC$955.80 million
P/E Ratio69.90
Dividend YieldN/A
BetaN/A

Headlines

Knight Therapeutics (TSE GUD) News Headlines

Source:
DateHeadline
FY2020 Earnings Forecast for Knight Therapeutics Inc (TSE:GUD) Issued By National Bank FinancialFY2020 Earnings Forecast for Knight Therapeutics Inc (TSE:GUD) Issued By National Bank Financial
www.americanbankingnews.com - July 1 at 8:34 AM
Bloom Burton Downgrades Knight Therapeutics (TSE:GUD) to AccumulateBloom Burton Downgrades Knight Therapeutics (TSE:GUD) to Accumulate
www.americanbankingnews.com - July 1 at 7:22 AM
FY2021 Earnings Forecast for Knight Therapeutics Inc Issued By National Bank Financial (TSE:GUD)FY2021 Earnings Forecast for Knight Therapeutics Inc Issued By National Bank Financial (TSE:GUD)
www.americanbankingnews.com - June 30 at 6:21 AM
Knight Therapeutics (TSE:GUD) PT Set at C$10.25 by Raymond JamesKnight Therapeutics (TSE:GUD) PT Set at C$10.25 by Raymond James
www.americanbankingnews.com - June 29 at 3:01 PM
National Bank Financial Lowers Knight Therapeutics (TSE:GUD) Price Target to C$8.25National Bank Financial Lowers Knight Therapeutics (TSE:GUD) Price Target to C$8.25
www.americanbankingnews.com - June 29 at 3:01 PM
Edited Transcript of GUD.TO earnings conference call or presentation 26-Jun-20 12:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 26-Jun-20 12:30pm GMT
finance.yahoo.com - June 27 at 12:36 AM
Knight Therapeutics Inc. announces voting results from the Annual MeetingKnight Therapeutics Inc. announces voting results from the Annual Meeting
finance.yahoo.com - June 25 at 11:42 PM
Knight Therapeutics (GUD) to Release Earnings on FridayKnight Therapeutics (GUD) to Release Earnings on Friday
www.americanbankingnews.com - June 19 at 10:52 AM
Knight Therapeutics Inc. Announces Further Update on Extension of First Quarter 2020 Filings due to COVID-19Knight Therapeutics Inc. Announces Further Update on Extension of First Quarter 2020 Filings due to COVID-19
finance.yahoo.com - May 29 at 6:54 PM
Knight to Present at the Jefferies 2020 Virtual Global Healthcare ConferenceKnight to Present at the Jefferies 2020 Virtual Global Healthcare Conference
finance.yahoo.com - May 27 at 5:17 PM
Knight Therapeutics Inc. Announces Extension of First Quarter 2020 Filings due to COVID-19Knight Therapeutics Inc. Announces Extension of First Quarter 2020 Filings due to COVID-19
finance.yahoo.com - April 30 at 6:14 PM
Profound Medical: The Prostate Market DisruptorProfound Medical: The Prostate Market Disruptor
seekingalpha.com - April 22 at 8:05 PM
Knight Announces the Re-Launch of Trelstar® in CanadaKnight Announces the Re-Launch of Trelstar® in Canada
finance.yahoo.com - April 20 at 7:32 AM
Knight Therapeutics Announces Approval of IBSRELA(TM) in CanadaKnight Therapeutics Announces Approval of IBSRELA(TM) in Canada
www.marketwatch.com - April 17 at 9:38 AM
Knight Therapeutics Announces Approval of IBSRELA™ in CanadaKnight Therapeutics Announces Approval of IBSRELA™ in Canada
finance.yahoo.com - April 17 at 9:38 AM
Knight Therapeutics Inc. Announces Triumvira Loan RepaymentKnight Therapeutics Inc. Announces Triumvira Loan Repayment
finance.yahoo.com - April 16 at 8:29 AM
Knight Therapeutics Inc. Announces Completion of its Normal Course Issuer BidKnight Therapeutics Inc. Announces Completion of its Normal Course Issuer Bid
finance.yahoo.com - April 15 at 10:20 PM
Edited Transcript of GUD.TO earnings conference call or presentation 30-Mar-20 9:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 30-Mar-20 9:30pm GMT
finance.yahoo.com - March 31 at 9:19 PM
Knight Announces Closing of Separation AgreementKnight Announces Closing of Separation Agreement
finance.yahoo.com - March 16 at 7:31 PM
One Oversold Biotech Stock to Consider TodayOne Oversold Biotech Stock to Consider Today
www.baystreet.ca - February 26 at 12:56 PM
Quebec, New Brunswick, Newfoundland, Nova Scotia and Manitoba join Alberta, Saskatchewan, in adding Knight’s PROBUPHINE® to their provincial drug plans in the fight against the opioid crisisQuebec, New Brunswick, Newfoundland, Nova Scotia and Manitoba join Alberta, Saskatchewan, in adding Knight’s PROBUPHINE® to their provincial drug plans in the fight against the opioid crisis
finance.yahoo.com - February 11 at 5:36 PM
TSX:GUD (KNIGHT THERAPEUTICS INC)TSX:GUD (KNIGHT THERAPEUTICS INC)
www.fool.ca - January 31 at 12:23 AM
Knight Partners with Debiopharm for the Commercialization of Trelstar(R) in CanadaKnight Partners with Debiopharm for the Commercialization of Trelstar(R) in Canada
www.marketwatch.com - January 8 at 3:39 PM
Knight Partners with Debiopharm for the Commercialization of Trelstar® in CanadaKnight Partners with Debiopharm for the Commercialization of Trelstar® in Canada
finance.yahoo.com - January 8 at 3:39 PM
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Bijuva(R) in CanadaKnight and TherapeuticsMD Announce Filing of New Drug Submission for Bijuva(R) in Canada
www.marketwatch.com - November 26 at 8:44 AM
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Bijuva® in CanadaKnight and TherapeuticsMD Announce Filing of New Drug Submission for Bijuva® in Canada
finance.yahoo.com - November 26 at 8:44 AM
GUD Medison ResolvedGUD Medison Resolved
finance.yahoo.com - November 21 at 7:58 PM
Edited Transcript of GUD.TO earnings conference call or presentation 12-Nov-19 10:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 12-Nov-19 10:30pm GMT
finance.yahoo.com - November 16 at 7:14 PM
Knight Therapeutics Reports Third Quarter 2019 ResultsKnight Therapeutics Reports Third Quarter 2019 Results
finance.yahoo.com - November 12 at 6:52 PM
Notice of Knight Therapeutics Third Quarter 2019 Results Conference CallNotice of Knight Therapeutics' Third Quarter 2019 Results Conference Call
finance.yahoo.com - November 5 at 7:37 AM
Knight Therapeutics and SIFI S.p.A. Announce Approval of NETILDEX™ in CanadaKnight Therapeutics and SIFI S.p.A. Announce Approval of NETILDEX™ in Canada
finance.yahoo.com - October 23 at 8:05 AM
Ballard, Knight at 52-Week HighsBallard, Knight at 52-Week Highs
www.baystreet.ca - October 22 at 1:23 PM
Knight Therapeutics Inc.Knight Therapeutics Inc.
www.baystreet.ca - October 21 at 1:09 PM
BRIEF-Knight Therapeutics To Acquire Grupo BiotoscanaBRIEF-Knight Therapeutics To Acquire Grupo Biotoscana
www.msn.com - October 21 at 8:08 AM
Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth PlatformKnight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform
finance.yahoo.com - October 21 at 8:08 AM
Medison Urges Knight Therapeutics and Jonathan Goodman to Aggressively Pursue Opportunities Created by Distressed Opioid Case TargetsMedison Urges Knight Therapeutics and Jonathan Goodman to Aggressively Pursue Opportunities Created by Distressed Opioid Case Targets
finance.yahoo.com - September 3 at 4:19 PM
Edited Transcript of GUD.TO earnings conference call or presentation 8-Aug-19 12:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 8-Aug-19 12:30pm GMT
finance.yahoo.com - August 11 at 12:12 PM
Knight Therapeutics Reports Second Quarter 2019 ResultsKnight Therapeutics Reports Second Quarter 2019 Results
finance.yahoo.com - August 8 at 9:22 AM
Notice of Knight Therapeutics Second Quarter 2019 Results Conference CallNotice of Knight Therapeutics' Second Quarter 2019 Results Conference Call
finance.yahoo.com - August 1 at 10:17 AM
Is Knight Therapeutics Inc. (TSE:GUD) Potentially Underrated?Is Knight Therapeutics Inc. (TSE:GUD) Potentially Underrated?
finance.yahoo.com - July 22 at 11:33 AM
Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc.Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc.
finance.yahoo.com - July 18 at 12:05 PM
Medison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight TherapeuticsMedison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight Therapeutics
finance.yahoo.com - July 9 at 11:34 AM
Knight Announces Filing of New Drug Submission for Ibsrela™ in CanadaKnight Announces Filing of New Drug Submission for Ibsrela™ in Canada
finance.yahoo.com - June 26 at 11:31 AM
Knight has less skin in Medimetriks through full loan repaymentKnight has less skin in Medimetriks through full loan repayment
finance.yahoo.com - June 18 at 6:19 PM
Is Knight Therapeutics Inc.'s (TSE:GUD) CEO Being Overpaid?Is Knight Therapeutics Inc.'s (TSE:GUD) CEO Being Overpaid?
finance.yahoo.com - June 7 at 7:52 PM
Knight to Present at the Jefferies 2019 Global Healthcare Conference in New York CityKnight to Present at the Jefferies 2019 Global Healthcare Conference in New York City
finance.yahoo.com - May 29 at 11:16 AM
Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!
www.msn.com - May 24 at 4:05 PM
Knight to Present at the National Bank Financial Markets 9th Annual Quebec Conference in TorontoKnight to Present at the National Bank Financial Markets 9th Annual Quebec Conference in Toronto
finance.yahoo.com - May 23 at 4:08 PM
Knight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York CityKnight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York City
finance.yahoo.com - May 15 at 9:07 PM
Edited Transcript of GUD.TO earnings conference call or presentation 9-May-19 12:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 9-May-19 12:30pm GMT
finance.yahoo.com - May 10 at 4:06 PM
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.